|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Net income | |||||
| Depreciation and amortization | |||||
| Depreciation on property and equipment | |||||
| Amortization on intangible assets | |||||
| Noncash lease expense | |||||
| Impairment of assets | |||||
| Impairment of strategic investment | |||||
| Equity-based compensation | |||||
| Deferred income tax expense (benefit) | |||||
| Amortization of revolver loan costs | |||||
| Gain on divestiture of a business | |||||
| Premium amortization (discount accretion) on marketable securities | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Prepaid revenue share fee | |||||
| Accounts payable | |||||
| Accrued and other long term liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Deferred rent | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Business combinations, net of cash acquired | |||||
| Purchases of marketable securities | |||||
| Proceeds from Sale and Maturity of Marketable Securities | |||||
| Proceeds from sales and maturities of marketable securities | |||||
| Proceeds from divestiture | |||||
| Purchase of strategic investment | |||||
| Purchases of property and equipment | |||||
| Purchases of intangible assets | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing activities: | |||||
| IPO proceeds, net of underwriter fees and issuance costs | |||||
| Repurchase of Class A Common Stock | |||||
| Proceeds from issuance of members’ equity, net of issuance costs | |||||
| Issuance of warrants | |||||
| Proceeds from the exercise of warrants | |||||
| Payment of dividend | |||||
| Payment of special dividend | |||||
| Distributions to members | |||||
| Tax distribution to members | |||||
| Deferred consideration payment | |||||
| Payment of taxes on net settled stock-based awards | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of period | |||||
| Exchange rate effect on cash and cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, end of period | |||||
Loading...